{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:37:08Z","timestamp":1790303828506,"version":"4.1.0"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Anterior uveitis (AU) is characterized by the inflammation of the iris and ciliary body and is the most frequent extra-articular manifestation of spondyloarthritis (SpA). In SpA patients, AU is typically described as unilateral alternating acute AU (AAU). Moreover, as AAU can be the initial clinical manifestation of SpA, ophthalmologists could play a key role in the early diagnosis of SpA. The diagnostic delay in SpA is associated with poorer outcomes, including functional impairment, reduced response to treatment, and lower quality of life. A well-structured screening of patients with AAU could facilitate the early diagnosis. Consequently, the interdisciplinary collaboration between ophthalmologists and rheumatologists is fundamental to reduce the diagnostic delays. A correct and early diagnosis of SpA, together with early treatment initiation is important prognostic factors. These measures are associated with better treatment responses and may help retard the development of structural damage, particularly in the era of biological therapies, which have significantly improved the care of patients with SpA. Although various algorithms have been proposed to guide the selection of appropriate candidates for rheumatology referral, to date, there are no formal guidelines or universally recognized criteria for referral. This review aimed to summarize the epidemiological, pathogenetic, clinical, and therapeutic aspects of AU associated with SpA as well as the ophthalmology-rheumatology interdisciplinary approach.<\/jats:p>","DOI":"10.4103\/sjopt.sjopt_240_24","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:01:19Z","timestamp":1735891279000},"page":"20-30","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A review on anterior uveitis and spondyloarthritis with a focus on the interdisciplinary approach between ophthalmologists and rheumatologists"],"prefix":"10.4103","volume":"39","author":[{"given":"Elena","family":"Bolletta","sequence":"first","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crescentini","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Gentile","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Citriniti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Macchioni","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marchesoni","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"},{"name":"Rheumatology, Humanitas San Pio X, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca De","family":"Simone","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Gozzi","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"},{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cimino","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy"},{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"R1-20250325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R2-20250325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"114","DOI":"10.22336\/rjo.2018.17","article-title":"Advances in the treatment of uveitis in patients with spondyloarthritis \u2013Is it the time for biologic therapy?","volume":"62","author":"Mitulescu","year":"2018","journal-title":"Rom J Ophthalmol"},{"key":"R4-20250325","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00002281-199807000-00006","article-title":"Acute anterior uveitis and spondyloarthropathies","volume":"10","author":"Feltkamp","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"R5-20250325","doi-asserted-by":"crossref","first-page":"9460187","DOI":"10.1155\/2018\/9460187","article-title":"The management of acute anterior uveitis complicating spondyloarthritis:Present and future","volume":"2018","author":"Biggioggero","year":"2018","journal-title":"Biomed Res Int"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"1759720X20951733","DOI":"10.1177\/1759720X20951733","article-title":"Uveitis in spondyloarthritis","volume":"12","author":"Rademacher","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/art.42658","article-title":"Shared and distinct gut microbiota in spondyloarthritis, acute anterior uveitis, and crohn's disease","volume":"76","author":"Essex","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part I):Classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part II):Validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"R10-20250325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/art.1780200401","article-title":"Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis","volume":"20","author":"Khan","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R12-20250325","doi-asserted-by":"crossref","first-page":"608134","DOI":"10.3389\/fimmu.2020.608134","article-title":"Recent developments in HLA B27 anterior uveitis","volume":"11","author":"Wakefield","year":"2020","journal-title":"Front Immunol"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/art.38873","article-title":"Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis","volume":"67","author":"Robinson","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41584-018-0097-2","article-title":"The microbiome and HLA-B27-associated acute anterior uveitis","volume":"14","author":"Rosenbaum","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.berh.2018.08.002","article-title":"Uveitis and spondyloarthropathies","volume":"31","author":"Sharma","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tim.2022.08.008","article-title":"The microbiome in HLA-B27-associated disease:Implications for acute anterior uveitis and recommendations for future studies","volume":"31","author":"Parthasarathy","year":"2023","journal-title":"Trends Microbiol"},{"key":"R17-20250325","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-associated reactive arthritis:Pathogenetic and clinical considerations","volume":"17","author":"Colmegna","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/BOR.0000000000000403","article-title":"New developments in uveitis associated with HLA B27","volume":"29","author":"Rosenbaum","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","article-title":"Role of human leukocyte antigens (HLA) in autoimmune diseases","volume":"5","author":"Bodis","year":"2018","journal-title":"Rheumatol Ther"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000310715","article-title":"Endogenous uveitis:An analysis of 1,417 cases","volume":"210","author":"Pivetti-Pezzi","year":"1996","journal-title":"Ophthalmologica"},{"key":"R21-20250325","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09273948.2013.855799","article-title":"The Manchester uveitis clinic:The first 3000 patients \u2013Epidemiology and casemix","volume":"23","author":"Jones","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3109\/09273948.2016.1158279","article-title":"Clinical patterns of uveitis in a tertiary center in North China","volume":"25","author":"Gao","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1076\/ocii.11.4.277.18260","article-title":"Changing patterns of intraocular inflammatory disease in Japan","volume":"11","author":"Wakabayashi","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"R24-20250325","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1080\/09273948.2016.1203957","article-title":"Land of the long white cloud:The spectrum of uveitis at a tertiary referral center in New Zealand","volume":"25","author":"Wong","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R25-20250325","first-page":"35","article-title":"Causes of uveitis in the general practice of ophthalmology","volume":"121","author":"McCannel","year":"1996","journal-title":"UCLA community-based uveitis study group. Am J Ophthalmol"},{"key":"R26-20250325","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1442-9071.2009.02082.x","article-title":"Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia","volume":"37","author":"de-la-Torre","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"R27-20250325","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/09273948.2017.1281424","article-title":"Pattern of uveitis in a referral hospital in Bangladesh","volume":"26","author":"Rahman","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R28-20250325","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis:A meta-analysis","volume":"18","author":"de Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R29-20250325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis:A systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R30-20250325","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","article-title":"Prevalence and characteristics of uveitis in the spondyloarthropathies:A systematic literature review","volume":"67","author":"Zeboulon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R31-20250325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajo.2021.03.049","article-title":"Classification criteria for spondyloarthritis\/HLA-B27-associated anterior uveitis","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R32-20250325","first-page":"419","article-title":"Gender-attributable differences in outcome of ankylosing spondylitis:Long-term results from the outcome in ankylosing spondylitis international study","volume":"55","author":"Webers","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R33-20250325","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/rheumatology\/kex057","article-title":"Ocular involvement in patients with spondyloarthritis","volume":"56","author":"Bacchiega","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20250325","doi-asserted-by":"crossref","first-page":"6632081","DOI":"10.1155\/2022\/6632081","article-title":"Clinical features and prevalence of spondyloarthritis in a cohort of Italian patients presenting with acute nongranulomatous anterior uveitis","volume":"2022","author":"Bolletta","year":"2022","journal-title":"J Immunol Res"},{"key":"R35-20250325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9394(14)78239-X","article-title":"Signs and symptoms of uveitis I. Anterior uveitis","volume":"47","author":"Hogan","year":"1959","journal-title":"Am J Ophthalmol"},{"key":"R36-20250325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","article-title":"Laser flare photometry:A noninvasive, objective, and quantitative method to measure intraocular inflammation","volume":"30","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol"},{"key":"R37-20250325","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ophtha.2009.07.025","article-title":"Hypopyon in patients with uveitis","volume":"117","author":"Zaidi","year":"2010","journal-title":"Ophthalmology"},{"key":"R38-20250325","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/08820538.2016.1170158","article-title":"Clinical features and complications of the HLA-B27-associated acute anterior uveitis:A metanalysis","volume":"32","author":"D'Ambrosio","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"R39-20250325","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0161-6420(98)99033-9","article-title":"Outcomes in anterior uveitis associated with the HLA-B27 haplotype","volume":"105","author":"Power","year":"1998","journal-title":"Ophthalmology"},{"key":"R40-20250325","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ophtha.2016.03.010","article-title":"Description and prevalence of spondyloarthritis in patients with anterior uveitis:The SENTINEL interdisciplinary collaborative project","volume":"123","author":"Juanola","year":"2016","journal-title":"Ophthalmology"},{"key":"R41-20250325","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10067-014-2768-y","article-title":"Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis","volume":"34","author":"Seo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R42-20250325","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s10067-022-06100-7","article-title":"Diagnostic delay in axial spondyloarthritis:A systematic review","volume":"41","author":"Hay","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R43-20250325","doi-asserted-by":"crossref","first-page":"101870","DOI":"10.1016\/j.berh.2023.101870","article-title":"Diagnostic delay in axial spondylarthritis:A lost battle?","volume":"37","author":"Barnett","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R44-20250325","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/rheumatology\/keaa807","article-title":"Diagnostic delay in axial spondyloarthritis:A systematic review and meta-analysis","volume":"60","author":"Zhao","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R45-20250325","first-page":"792","article-title":"Characterization of uveitis associated with spondyloarthritis","volume":"16","author":"Rosenbaum","year":"1989","journal-title":"J Rheumatol"},{"key":"R46-20250325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/03009740802385423","article-title":"Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis","volume":"38","author":"Chung","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"R47-20250325","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1136\/annrheumdis-2014-205358","article-title":"A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis:The DUET (Dublin Uveitis Evaluation Tool)","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R48-20250325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00417-014-2772-6","article-title":"Acute anterior uveitis and undiagnosed spondyloarthritis:Usefulness of Berlin criteria","volume":"253","author":"Wach","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R49-20250325","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3899\/jrheum.170036","article-title":"Sacroiliac joint magnetic resonance imaging in asymptomatic patients with recurrent acute anterior uveitis:A proof-of-concept study","volume":"44","author":"Oliveira","year":"2017","journal-title":"J Rheumatol"},{"key":"R50-20250325","doi-asserted-by":"crossref","first-page":"e000553","DOI":"10.1136\/rmdopen-2017-000553","article-title":"Prevalence of axial spondyloarthritis in patients with acute anterior uveitis:A cross-sectional study utilising MRI","volume":"4","author":"Sykes","year":"2018","journal-title":"RMD Open"},{"key":"R51-20250325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/diagnostics12010161","article-title":"The prevalence of MRI-defined sacroiliitis and classification of spondyloarthritis in patients with acute anterior uveitis:A longitudinal single-centre cohort study","volume":"12","author":"Bubova","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R52-20250325","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.42315","article-title":"Keep an eye on the back:Spondyloarthritis in patients with acute anterior uveitis","volume":"75","author":"Rademacher","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R53-20250325","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/art.24636","article-title":"Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis","volume":"60","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R54-20250325","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/rheumatology\/kez090","article-title":"Determinants of diagnostic delay in axial spondyloarthritis:An analysis based on linked claims and patient-reported survey data","volume":"58","author":"Redeker","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R55-20250325","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00296-018-4094-1","article-title":"Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement:A consensus statement","volume":"38","author":"Olivieri","year":"2018","journal-title":"Rheumatol Int"},{"key":"R56-20250325","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/annrheumdis-2014-207151","article-title":"Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis","volume":"74","author":"Poddubnyy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R57-20250325","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3899\/jrheum.170115","article-title":"The effect of anterior uveitis and previously undiagnosed spondyloarthritis:Results from the DUET cohort","volume":"44","author":"O'Rourke","year":"2017","journal-title":"J Rheumatol"},{"key":"R58-20250325","first-page":"2198","article-title":"Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis","volume":"27","author":"Pato","year":"2000","journal-title":"J Rheumatol"},{"key":"R59-20250325","doi-asserted-by":"crossref","first-page":"e0230560","DOI":"10.1371\/journal.pone.0230560","article-title":"Impact of systemic treatments on the course of HLA-B27-associated uveitis:A retrospective study of 101 patients","volume":"15","author":"Bouzid","year":"2020","journal-title":"PLoS One"},{"key":"R60-20250325","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/ard.2006.052878","article-title":"Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis:A multicentre randomised controlled trial","volume":"65","author":"Braun","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R61-20250325","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/eye.2008.198","article-title":"Methotrexate:An option for preventing the recurrence of acute anterior uveitis","volume":"23","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2009","journal-title":"Eye (Lond)"},{"key":"R62-20250325","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Benitez-Del-Castillo","year":"2000","journal-title":"Eye (Lond)"},{"key":"R63-20250325","first-page":"1277","article-title":"Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period","volume":"30","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2003","journal-title":"J Rheumatol"},{"key":"R64-20250325","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3129\/i07-085","article-title":"Early clinical experience with leflunomide in uveitis","volume":"42","author":"Roy","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"R65-20250325","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Ka\u00e7maz","year":"2010","journal-title":"Ophthalmology"},{"key":"R66-20250325","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"R67-20250325","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): A multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"R68-20250325","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study:VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"R69-20250325","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/09273948.2017.1411518","article-title":"Randomized controlled study to evaluate the efficacy of adalimumab in patients with different forms of refractory uveitis","volume":"26","author":"Mackensen","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R70-20250325","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","article-title":"Therapeutic use of infliximab in sight threatening uveitis:Retrospective analysis of efficacy, safety, and limiting factors","volume":"64","author":"Bodaghi","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R71-20250325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09273948.2012.723107","article-title":"Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis","volume":"21","author":"Cordero-Coma","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"R72-20250325","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1185\/03007995.2014.969368","article-title":"Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis:An analysis of a large US claims database","volume":"30","author":"Wendling","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"R73-20250325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ncprheum0097","article-title":"Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis?","volume":"2","author":"Levy-Clarke","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R74-20250325","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3899\/jrheum.131289","article-title":"Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis","volume":"41","author":"van Denderen","year":"2014","journal-title":"J Rheumatol"},{"key":"R75-20250325","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis:Results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R76-20250325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archopht.121.4.437","article-title":"Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate","volume":"121","author":"Foster","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R77-20250325","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy:A retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R78-20250325","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210931","article-title":"Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis:Results from the Swedish biologics register","volume":"76","author":"Lie","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R79-20250325","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semarthrit.2011.05.005","article-title":"New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases","volume":"41","author":"Wendling","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R80-20250325","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis?A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R81-20250325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3899\/jrheum.180312","article-title":"Reduced occurrence rate of acute anterior uveitis in ankylosing spondylitis treated with golimumab \u2013The GO-EASY study","volume":"46","author":"van Bentum","year":"2019","journal-title":"J Rheumatol"},{"key":"R82-20250325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2016.03.002","article-title":"Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients","volume":"46","author":"Calvo-R\u00edo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R83-20250325","doi-asserted-by":"crossref","first-page":"1759720X211003803","DOI":"10.1177\/1759720X211003803","article-title":"Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment:Final 2-year results from the multicenter phase IV C-VIEW study","volume":"13","author":"van der Horst-Bruinsma","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R84-20250325","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/acr.22848","article-title":"Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis","volume":"68","author":"Rudwaleit","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R85-20250325","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"R86-20250325","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13075-021-02549-0","article-title":"Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A:A systematic review, a pairwise and network meta-analysis of randomized controlled trials","volume":"23","author":"Roche","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R87-20250325","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/annrheumdis-2021-220420","article-title":"Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care:Does the choice of biological therapy matter?","volume":"80","author":"Lindstr\u00f6m","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R88-20250325","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/ard-2024-225933","article-title":"Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab:Pooled results from phase 2b\/3 trials","volume":"83","author":"Brown","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R89-20250325","doi-asserted-by":"crossref","first-page":"e12527","DOI":"10.1111\/dth.12527","article-title":"Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis","volume":"30","author":"Mugheddu","year":"2017","journal-title":"Dermatol Ther"},{"key":"R92-20250325","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in patients with ankylosing spondylitis:A phase II, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R94-20250325","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaophthalmol.2024.2439","article-title":"Filgotinib in active noninfectious uveitis:The HUMBOLDT randomized clinical trial","volume":"142","author":"Srivastava","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R95-20250325","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/art.42788","article-title":"Incidence of uveitis in patients with axial spondylarthritis treated with biologics or targeted synthetics:A systematic review and network meta-analysis","volume":"76","author":"Bechman","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R96-20250325","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA):Updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R97-20250325","doi-asserted-by":"crossref","first-page":"105469","DOI":"10.1016\/j.jbspin.2022.105469","article-title":"The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis:Similarities and differences","volume":"90","author":"Coates","year":"2023","journal-title":"Joint Bone Spine"},{"key":"R98-20250325","first-page":"438","article-title":"Management of concomitant inflammatory bowel disease or uveitis in patients with psoriatic arthritis:An updated review informing the 2021 GRAPPA treatment recommendations","volume":"50","author":"Jadon","year":"2023","journal-title":"J Rheumatol"},{"key":"R99-20250325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis:2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_240_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:50Z","timestamp":1786647290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_240_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/sjopt.sjopt_240_24","relation":{},"ISSN":["1319-4534","2542-6680"],"issn-type":[{"value":"1319-4534","type":"print"},{"value":"2542-6680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-09-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}